Inclacumab (Anti-P-Selectin / CD62p)

Inclacumab (Anti-P-Selectin / CD62p) is a humanized monoclonal IgG4 antibody selectively targets P-selectin. It reduces cell adhesion showing potential for prevention of sickle cell disease (SCD). MW :150 KD.

• Supplier: Selleck Chemicals
• Product #: A2616
• Sku #: A2616-1mg